Day Range0.510 - 0.540 | 52 Wk Range0.360 - 1.890 | Open / Close0.510 / - | Float / Outstanding86.224M / 88.511M |
Vol / Avg.21.687K / 140.265K | Mkt Cap47.778M | P/E13.000 | 50d Avg. Price0.460 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float86.224M | EPS0.040 |
Lipocine Stock (NASDAQ: LPCN) stock price, news, charts, stock research, profile.
Day Range0.510 - 0.540 | 52 Wk Range0.360 - 1.890 | Open / Close0.510 / - | Float / Outstanding86.224M / 88.511M |
Vol / Avg.21.687K / 140.265K | Mkt Cap47.778M | P/E13.000 | 50d Avg. Price0.460 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float86.224M | EPS0.040 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-08 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | -0.030 | 0.0000 | ||||
REV | 700.000K | 0 | -700.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Lipocine (NASDAQ: LPCN) through any online brokerage.
Other companies in Lipocine’s space includes: Cumberland (NASDAQ:CPIX), Satsuma Pharmaceuticals (NASDAQ:STSA), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP) and Longboard Pharmaceuticals (NASDAQ:LBPH).
The latest price target for Lipocine (NASDAQ: LPCN) was reported by HC Wainwright & Co. on Thursday, August 26, 2021. The analyst firm set a price target for 3.50 expecting LPCN to rise to within 12 months (a possible 548.39% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Lipocine (NASDAQ: LPCN) is $0.5398 last updated Today at January 31, 2023 at 4:07 PM UTC.
There are no upcoming dividends for Lipocine.
Lipocine’s Q4 earnings are confirmed for Wednesday, March 8, 2023.
There is no upcoming split for Lipocine.
Lipocine is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Lipocine Stock (NASDAQ: LPCN) stock price, news, charts, stock research, profile.
Day Range0.510 - 0.540 | 52 Wk Range0.360 - 1.890 | Open / Close0.510 / - | Float / Outstanding86.224M / 88.511M |
Vol / Avg.21.687K / 140.265K | Mkt Cap47.778M | P/E13.000 | 50d Avg. Price0.460 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float86.224M | EPS0.040 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-08 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | -0.030 | 0.0000 | ||||
REV | 700.000K | 0 | -700.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Lipocine (NASDAQ: LPCN) through any online brokerage.
Other companies in Lipocine’s space includes: Cumberland (NASDAQ:CPIX), Satsuma Pharmaceuticals (NASDAQ:STSA), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP) and Longboard Pharmaceuticals (NASDAQ:LBPH).
The latest price target for Lipocine (NASDAQ: LPCN) was reported by HC Wainwright & Co. on Thursday, August 26, 2021. The analyst firm set a price target for 3.50 expecting LPCN to rise to within 12 months (a possible 548.39% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Lipocine (NASDAQ: LPCN) is $0.5398 last updated Today at January 31, 2023 at 4:07 PM UTC.
There are no upcoming dividends for Lipocine.
Lipocine’s Q4 earnings are confirmed for Wednesday, March 8, 2023.
There is no upcoming split for Lipocine.
Lipocine is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Lipocine Stock (NASDAQ: LPCN) stock price, news, charts, stock research, profile.
Day Range0.510 - 0.540 | 52 Wk Range0.360 - 1.890 | Open / Close0.510 / - | Float / Outstanding86.224M / 88.511M |
Vol / Avg.21.687K / 140.265K | Mkt Cap47.778M | P/E13.000 | 50d Avg. Price0.460 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float86.224M | EPS0.040 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-08 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | -0.030 | 0.0000 | ||||
REV | 700.000K | 0 | -700.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Lipocine (NASDAQ: LPCN) through any online brokerage.
Other companies in Lipocine’s space includes: Cumberland (NASDAQ:CPIX), Satsuma Pharmaceuticals (NASDAQ:STSA), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP) and Longboard Pharmaceuticals (NASDAQ:LBPH).
The latest price target for Lipocine (NASDAQ: LPCN) was reported by HC Wainwright & Co. on Thursday, August 26, 2021. The analyst firm set a price target for 3.50 expecting LPCN to rise to within 12 months (a possible 548.39% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Lipocine (NASDAQ: LPCN) is $0.5398 last updated Today at January 31, 2023 at 4:07 PM UTC.
There are no upcoming dividends for Lipocine.
Lipocine’s Q4 earnings are confirmed for Wednesday, March 8, 2023.
There is no upcoming split for Lipocine.
Lipocine is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Lipocine Stock (NASDAQ: LPCN) stock price, news, charts, stock research, profile.
Day Range0.510 - 0.540 | 52 Wk Range0.360 - 1.890 | Open / Close0.510 / - | Float / Outstanding86.224M / 88.511M |
Vol / Avg.21.687K / 140.265K | Mkt Cap47.778M | P/E13.000 | 50d Avg. Price0.460 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float86.224M | EPS0.040 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-08 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | -0.030 | 0.0000 | ||||
REV | 700.000K | 0 | -700.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Lipocine (NASDAQ: LPCN) through any online brokerage.
Other companies in Lipocine’s space includes: Cumberland (NASDAQ:CPIX), Satsuma Pharmaceuticals (NASDAQ:STSA), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP) and Longboard Pharmaceuticals (NASDAQ:LBPH).
The latest price target for Lipocine (NASDAQ: LPCN) was reported by HC Wainwright & Co. on Thursday, August 26, 2021. The analyst firm set a price target for 3.50 expecting LPCN to rise to within 12 months (a possible 548.39% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Lipocine (NASDAQ: LPCN) is $0.5398 last updated Today at January 31, 2023 at 4:07 PM UTC.
There are no upcoming dividends for Lipocine.
Lipocine’s Q4 earnings are confirmed for Wednesday, March 8, 2023.
There is no upcoming split for Lipocine.
Lipocine is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Lipocine Stock (NASDAQ: LPCN) stock price, news, charts, stock research, profile.
Day Range0.510 - 0.540 | 52 Wk Range0.360 - 1.890 | Open / Close0.510 / - | Float / Outstanding86.224M / 88.511M |
Vol / Avg.21.687K / 140.265K | Mkt Cap47.778M | P/E13.000 | 50d Avg. Price0.460 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float86.224M | EPS0.040 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-08 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | -0.030 | 0.0000 | ||||
REV | 700.000K | 0 | -700.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Lipocine (NASDAQ: LPCN) through any online brokerage.
Other companies in Lipocine’s space includes: Cumberland (NASDAQ:CPIX), Satsuma Pharmaceuticals (NASDAQ:STSA), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP) and Longboard Pharmaceuticals (NASDAQ:LBPH).
The latest price target for Lipocine (NASDAQ: LPCN) was reported by HC Wainwright & Co. on Thursday, August 26, 2021. The analyst firm set a price target for 3.50 expecting LPCN to rise to within 12 months (a possible 548.39% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Lipocine (NASDAQ: LPCN) is $0.5398 last updated Today at January 31, 2023 at 4:07 PM UTC.
There are no upcoming dividends for Lipocine.
Lipocine’s Q4 earnings are confirmed for Wednesday, March 8, 2023.
There is no upcoming split for Lipocine.
Lipocine is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Lipocine Stock (NASDAQ: LPCN) stock price, news, charts, stock research, profile.
Day Range0.510 - 0.540 | 52 Wk Range0.360 - 1.890 | Open / Close0.510 / - | Float / Outstanding86.224M / 88.511M |
Vol / Avg.21.687K / 140.265K | Mkt Cap47.778M | P/E13.000 | 50d Avg. Price0.460 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float86.224M | EPS0.040 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-08 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | -0.030 | 0.0000 | ||||
REV | 700.000K | 0 | -700.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Lipocine (NASDAQ: LPCN) through any online brokerage.
Other companies in Lipocine’s space includes: Cumberland (NASDAQ:CPIX), Satsuma Pharmaceuticals (NASDAQ:STSA), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP) and Longboard Pharmaceuticals (NASDAQ:LBPH).
The latest price target for Lipocine (NASDAQ: LPCN) was reported by HC Wainwright & Co. on Thursday, August 26, 2021. The analyst firm set a price target for 3.50 expecting LPCN to rise to within 12 months (a possible 548.39% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Lipocine (NASDAQ: LPCN) is $0.5398 last updated Today at January 31, 2023 at 4:07 PM UTC.
There are no upcoming dividends for Lipocine.
Lipocine’s Q4 earnings are confirmed for Wednesday, March 8, 2023.
There is no upcoming split for Lipocine.
Lipocine is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Lipocine Stock (NASDAQ: LPCN) stock price, news, charts, stock research, profile.
Day Range0.510 - 0.540 | 52 Wk Range0.360 - 1.890 | Open / Close0.510 / - | Float / Outstanding86.224M / 88.511M |
Vol / Avg.21.687K / 140.265K | Mkt Cap47.778M | P/E13.000 | 50d Avg. Price0.460 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float86.224M | EPS0.040 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-08 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | -0.030 | 0.0000 | ||||
REV | 700.000K | 0 | -700.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Lipocine (NASDAQ: LPCN) through any online brokerage.
Other companies in Lipocine’s space includes: Cumberland (NASDAQ:CPIX), Satsuma Pharmaceuticals (NASDAQ:STSA), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP) and Longboard Pharmaceuticals (NASDAQ:LBPH).
The latest price target for Lipocine (NASDAQ: LPCN) was reported by HC Wainwright & Co. on Thursday, August 26, 2021. The analyst firm set a price target for 3.50 expecting LPCN to rise to within 12 months (a possible 548.39% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Lipocine (NASDAQ: LPCN) is $0.5398 last updated Today at January 31, 2023 at 4:07 PM UTC.
There are no upcoming dividends for Lipocine.
Lipocine’s Q4 earnings are confirmed for Wednesday, March 8, 2023.
There is no upcoming split for Lipocine.
Lipocine is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Lipocine Stock (NASDAQ: LPCN) stock price, news, charts, stock research, profile.
Day Range0.510 - 0.540 | 52 Wk Range0.360 - 1.890 | Open / Close0.510 / - | Float / Outstanding86.224M / 88.511M |
Vol / Avg.21.687K / 140.265K | Mkt Cap47.778M | P/E13.000 | 50d Avg. Price0.460 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float86.224M | EPS0.040 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-08 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | -0.030 | 0.0000 | ||||
REV | 700.000K | 0 | -700.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Lipocine (NASDAQ: LPCN) through any online brokerage.
Other companies in Lipocine’s space includes: Cumberland (NASDAQ:CPIX), Satsuma Pharmaceuticals (NASDAQ:STSA), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP) and Longboard Pharmaceuticals (NASDAQ:LBPH).
The latest price target for Lipocine (NASDAQ: LPCN) was reported by HC Wainwright & Co. on Thursday, August 26, 2021. The analyst firm set a price target for 3.50 expecting LPCN to rise to within 12 months (a possible 548.39% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Lipocine (NASDAQ: LPCN) is $0.5398 last updated Today at January 31, 2023 at 4:07 PM UTC.
There are no upcoming dividends for Lipocine.
Lipocine’s Q4 earnings are confirmed for Wednesday, March 8, 2023.
There is no upcoming split for Lipocine.
Lipocine is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Lipocine Stock (NASDAQ: LPCN) stock price, news, charts, stock research, profile.
Day Range0.510 - 0.540 | 52 Wk Range0.360 - 1.890 | Open / Close0.510 / - | Float / Outstanding86.224M / 88.511M |
Vol / Avg.21.687K / 140.265K | Mkt Cap47.778M | P/E13.000 | 50d Avg. Price0.460 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float86.224M | EPS0.040 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-08 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | -0.030 | 0.0000 | ||||
REV | 700.000K | 0 | -700.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Lipocine (NASDAQ: LPCN) through any online brokerage.
Other companies in Lipocine’s space includes: Cumberland (NASDAQ:CPIX), Satsuma Pharmaceuticals (NASDAQ:STSA), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP) and Longboard Pharmaceuticals (NASDAQ:LBPH).
The latest price target for Lipocine (NASDAQ: LPCN) was reported by HC Wainwright & Co. on Thursday, August 26, 2021. The analyst firm set a price target for 3.50 expecting LPCN to rise to within 12 months (a possible 548.39% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Lipocine (NASDAQ: LPCN) is $0.5398 last updated Today at January 31, 2023 at 4:07 PM UTC.
There are no upcoming dividends for Lipocine.
Lipocine’s Q4 earnings are confirmed for Wednesday, March 8, 2023.
There is no upcoming split for Lipocine.
Lipocine is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.